The immune response: targets for the treatment of severe sepsis

Aline M Bernard1, Gordon R Bernard

  • 1Division of Critical Care, Department of Pediatrics, University of Colorado School of Medicine, 13121 E 17th Avenue, MS 8414, Aurora, CO 80045-2535, USA ; Division of Pediatric Critical Care, Children's Hospital Colorado, 13123 East 16th Avenue, Aurora, CO 80045, USA.

Insights

Severe sepsis involves extreme inflammation and coagulation, leading to immune paralysis. This review explores therapies targeting inflammation, immune response modulation, and coagulation to improve sepsis treatment.

Area of Science:

  • Critical care medicine
  • Immunology
  • Hematology

Background:

  • Severe sepsis presents a complex interplay of systemic inflammation and coagulation activation.
  • This often results in a paradoxical state of immune suppression, hindering effective host defense.
  • The coagulation-inflammation cycle is a critical factor in sepsis pathophysiology.

Purpose of the Study:

  • To review current and potential therapies for severe sepsis.
  • To explore strategies for modulating the inflammatory and immune responses.
  • To examine approaches for managing the coagulation cascade in sepsis.

Main Methods:

  • Literature review of clinical and preclinical studies on sepsis therapies.
  • Analysis of therapeutic targets within the inflammatory and coagulation pathways.
  • Discussion of immunomodulatory strategies, both stimulatory and suppressive.

Main Results:

  • Multiple therapeutic targets exist along the inflammatory cascade.
  • Modulating the host immune response offers potential treatment avenues.
  • Controlling the hypercoagulable state is crucial for managing sepsis.

Conclusions:

  • Targeting inflammation, immune response, and coagulation offers multifaceted therapeutic opportunities.
  • Further research is needed to optimize sepsis treatment strategies.
  • Developing effective therapies requires a comprehensive understanding of the coagulation-inflammation cycle.

Related Concept Videos

Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...